MedPath

The project intends to look for biological markers in the urine and blood that can detect kidney injury in the transplanted kidney in patients undergone kidney transplantation surgery

Not Applicable
Conditions
Health Condition 1: N185- Chronic kidney disease, stage 5
Registration Number
CTRI/2019/10/021519
Lead Sponsor
Intra Mural Grant from All India Institute of Medical Sciences New Delhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Patients must be aged above 18

2. Patients willing to participate in the study

3. Immunologic higher risks (PRA > 20%, HLA mismatches >= 1).

4. Cross match negative

Exclusion Criteria

1. Patients who do not provide consent for the study

2. Age group <18 years.

3. Non-renal allograft patients

4. No Urine output

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess the pattern of blood and urine biomarker (FOXP3, OX40, PD1 and TIM3) excretion among post renal allograft patients at different time pointTimepoint: 0 day <br/ ><br>5th day <br/ ><br>9th day <br/ ><br>14th day
Secondary Outcome Measures
NameTimeMethod
To correlate the biomarker expression with biopsy proven acute kidney allograft injury (acute allograft rejection or acute tubular necrosis or calcineurin-inhibitor nephrotoxicity) during post transplantation surgeryTimepoint: 0 day <br/ ><br>5th day <br/ ><br>9th day <br/ ><br>14th day
© Copyright 2025. All Rights Reserved by MedPath